THE MORTALITY FROM THROMBOEMBOLISM FOLLOWING GYNECOLOGICAL OPERATIONS WITHOUT ANTI-COAGULATION TREATMENT

被引：8
|
作者：
STROBEL, E
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 1981年 / 41卷 / 11期
关键词：
D O I：
10.1055/s-2008-1036983
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：749 / 753
页数：5
相关论文
共 50 条
  • [21] An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis
    Tripodi, Armando
    Primignani, Massimo
    Chantarangkul, Veena
    Dell'Era, Alessandra
    Clerici, Marigrazia
    de Franchis, Roberto
    Colombo, Massimo
    Mannucci, Pier Mannuccio
    GASTROENTEROLOGY, 2009, 137 (06) : 2105 - 2111
  • [22] Effects of anti-coagulation and/or anti-platelet drugs on secondary hemorrhage following endoscopic submucosal dissection in patients with gastric tumors
    Kawai, Naoki
    Abe, Takashi
    Ebara, Ryouichi
    Mizutani, Masayo
    Okada, Akiyoshi
    Wada, Shigeo
    Oshita, Masahide
    Sato, Nobuhiro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A193 - A193
  • [23] An Institutional Survey of the Use of Anti-Coagulation for Deep Vein Thromboses Below the Knee: What Is the Treatment Standard?
    Robertson, T. Calloway
    Milner, Ross
    JOURNAL OF VASCULAR SURGERY, 2011, 54 (05) : 1545 - 1545
  • [24] Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxaban
    Oliver Königsbrügge
    Peter Quehenberger
    Sabine Belik
    Günter Weigel
    Christoph Seger
    Andrea Griesmacher
    Ingrid Pabinger
    Cihan Ay
    Annals of Hematology, 2015, 94 : 1463 - 1471
  • [25] Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxaban
    Koenigsbruegge, Oliver
    Quehenberger, Peter
    Belik, Sabine
    Weigel, Guenter
    Seger, Christoph
    Griesmacher, Andrea
    Pabinger, Ingrid
    Ay, Cihan
    ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1463 - 1471
  • [26] COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment
    Li-Hua Liu
    Yang-Zhao Zhou
    Tian-Yu Li
    Da-Bin Kuang
    Qun Liang
    Lei Chen
    Da-Feng Yang
    Xia Zhang
    Sheng-Lan Tan
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 730 - 738
  • [27] COVID-19 vaccination and short-term anti-coagulation levels in warfarin treatment: correspondence
    Daungsupawong, Hinpetch
    Wiwanitkit, Viroj
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (07) : 1237 - 1238
  • [28] COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment
    Liu, Li-Hua
    Zhou, Yang-Zhao
    Li, Tian-Yu
    Kuang, Da-Bin
    Liang, Qun
    Chen, Lei
    Yang, Da-Feng
    Zhang, Xia
    Tan, Sheng-Lan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (04) : 730 - 738
  • [29] Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic
    Mohamed S. Zaghloul
    Momodou Jammeh
    Andrew Gibson
    Suhong Luo
    Kelley Chadwick-Mansker
    Qianjin Liu
    Yan Yan
    Mohamed A. Zayed
    Thrombosis Journal, 21
  • [30] Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study
    Goebel, Sebastian
    Prochaska, Juergen H.
    Eggebrecht, Lisa
    Schmitz, Ronja
    Juenger, Claus
    Lamparter, Heidrun
    Nagler, Markus
    Keller, Karsten
    Coldewey, Meike
    Troebs, Sven-Oliver
    Diestelmeier, Simon
    Schwuchow-Thonke, Soeren
    Bickel, Christoph
    Lauterbach, Michael
    Lackner, Karl J.
    ten Cate, Hugo
    Muenzel, Thomas
    Hardt, Roland
    Wild, Philipp S.
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (11) : 1930 - 1939
12345